News | Implantable Cardiac Monitor (ICM) | July 09, 2019

Researchers File Patent for Tiny Blood Flow Sensor

Micro-medical device continuously measures blood flow through aorta in real time

Researchers File Patent for Tiny Blood Flow Sensor

Image courtesy of Flinders University

Researchers File Patent for Tiny Blood Flow Sensor

Image courtesy of Flinders University

July 9, 2019 — South Australian researchers are developing a tiny fiber-optic sensor, which has the potential to change the way blood flow is monitored. The device is so small that it can potentially be used to monitor newborn and premature babies.

Researchers from Flinders University in Adelaide have filed a provision patent for the micro-medical device that can continuously measure blood flow through the aorta and in real-time.

Research leader Strategic Professor John Arkwright said the device could be a game-changer for people in intensive care and undergoing surgical procedures.

“It’s a far more responsive measurement compared to traditional blood flow monitoring – and without life-threatening delays in the period snapshot provided by current blood flow practices using ultrasound or thermo-dilution,” he said.

But Flinders University biomedical engineer Albert Ruiz-Vargas, Ph.D., who helped develop the device, said additional funding was needed to engineer the device.

The project’s chief investigator said more research was required to determine how the sensor would behave under physiological conditions and to examine different encapsulations.

“The proof-of-concept prototype is potentially a low-cost device which has passed initial testing in a heart-lung machine,” Ruiz-Vargas said. “It can be inserted through a small keyhole aperture in the skin into the femoral artery in individuals where heart function is compromised and is so small it can even measure small changes in flow in the tiny blood vessels of infants.

“It’s a simple design, which can give readouts similar to a pulsating heartbeat response on a laptop or nearby screen.”

While the cardiac flow monitoring probe was developed for use in neonates in the intensive care unit, it could be used for patients of all ages, including cardiac bypass patients.

“Basically, neonates are prone to having more changes in blood flow and that can mean damage to any organs or the brain, because their vessels are more fragile,” Ruiz-Vargas said. “What we’ve got so far, it gives us a measurement every 30 minutes and has a lot of operator errors. With our device that won’t happen because it doesn’t need expertise (to control it). You just put it inside the body and it will measure continuously and all you need to do is watch the blood flow.”

He said he hoped the device would be picked up for further development and introduction into regular intensive care and surgical procedures.

“Optical flow sensor for continuous invasive measurement of blood flow velocity” was published in the Journal of Biophotonics.

For more information: www.onlinelibrary.wiley.com

Reference

1. Ruiz-Vargas A., Morris S.A., Hartley R.H., et al. Optical flow sensor for continuous invasive measurement of blood flow velocity. Journal of Biophotonics, May 18, 2019. https://doi.org/10.1002/jbio.201900139

Related Content

U.S. Soldiers Have Worse Heart Health Than Civilians
News | Cardiac Diagnostics | June 06, 2019
Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian...
Late Dinner and No Breakfast Worsens Outcomes After Heart Attack
News | Cardiac Diagnostics | May 23, 2019
People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack, according to research...
HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy
News | Cardiac Diagnostics | May 14, 2019
The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement with guidance on the evaluation and...
New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
AHA Statement Warns Hookah Smoking May Harm the Heart
News | Cardiac Diagnostics | March 08, 2019
Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels...
PTSD Alone Does Not Increase Heart Disease Risk in Veterans
News | Cardiac Diagnostics | February 20, 2019
February 20, 2019 — Post-traumatic stress disorder (PTSD) by itself does not explain the...
Hormone Therapy May Increase Cardiovascular Risk During Gender Transition
News | Cardiac Diagnostics | February 18, 2019
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular...
Overlay Init